These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27303095)

  • 1. Mepolizumab.
    Cada DJ; Bindler RJ; Baker DE
    Hosp Pharm; 2016 May; 51(5):405-14. PubMed ID: 27303095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patiromer.
    Cada DJ; Dang J; Baker DE
    Hosp Pharm; 2016 Apr; 51(4):328-36. PubMed ID: 27303081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridine Triacetate.
    Cada DJ; Mbogu U; Bindler RJ; Baker DE
    Hosp Pharm; 2016 Jun; 51(6):484-8. PubMed ID: 27354750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex.
    Cada DJ; Levien TL; Baker DE
    Hosp Pharm; 2016 Jul; 51(7):585-96. PubMed ID: 27559192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elbasvir/Grazoprevir.
    Cada DJ; Kim AP; Baker DE
    Hosp Pharm; 2016 Sep; 51(8):665-686. PubMed ID: 27698508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary Drug Review: Naldemedine.
    Baker DE
    Hosp Pharm; 2017 Jul; 52(7):464-468. PubMed ID: 29276274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secukinumab.
    Cada DJ; Baker DE; Panther SG; PharmD KI
    Hosp Pharm; 2015 Sep; 50(8):714-27. PubMed ID: 26823621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary Drug Review: Ocrelizumab.
    Ali ZK; Baker DE
    Hosp Pharm; 2017 Oct; 52(9):599-606. PubMed ID: 29276296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary Drug Review: Belumosudil.
    Levien TL; Baker DE
    Hosp Pharm; 2022 Aug; 57(4):435-441. PubMed ID: 35898245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary Drug Review: Edaravone.
    Ali ZK; Baker DE
    Hosp Pharm; 2017 Dec; 52(11):732-736. PubMed ID: 29276251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulary Drug Review: Odevixibat.
    Levien TL; Baker DE
    Hosp Pharm; 2023 Apr; 58(2):125-133. PubMed ID: 36890950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofosbuvir.
    Cada DJ; Cong J; Baker DE
    Hosp Pharm; 2014 May; 49(5):466-78. PubMed ID: 24958960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulary Drug Reviews: Glecaprevir/Pibrentasvir.
    Levien TL; Baker DE
    Hosp Pharm; 2018 Apr; 53(2):75-84. PubMed ID: 29581598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Degludec/Liraglutide.
    Baker DE
    Hosp Pharm; 2017 May; 52(5):374-380. PubMed ID: 28804155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide.
    Baker DE; Demaris K
    Hosp Pharm; 2016 Nov; 51(10):847-854. PubMed ID: 27928191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daclizumab.
    Kim AP; Baker DE
    Hosp Pharm; 2016 Dec; 51(11):928-939. PubMed ID: 28057953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary Drug Review: Sufentanil Sublingual.
    Baker DE
    Hosp Pharm; 2019 Aug; 54(4):222-228. PubMed ID: 31320770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulary Drug Reviews: Nirsevimab.
    Levien TL; Baker DE
    Hosp Pharm; 2024 Apr; 59(2):138-145. PubMed ID: 38450347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perampanel.
    Cada DJ; Levien TL; Baker DE
    Hosp Pharm; 2013 Apr; 48(4):321-31. PubMed ID: 24421482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lixisenatide.
    Baker DE; Levien TL
    Hosp Pharm; 2017 Jan; 52(1):65-80. PubMed ID: 28179743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.